SEC Form 4 · accession 0000914190-16-000764
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin S Gould
Officer — SVP Clinical Controls
Period of report
Aug 18, 2016
Accepted (ET)
Aug 22, 2016 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,191 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $106.59 | Aug 18, 2016 | A | 17,371 | A | — | Aug 18, 2023 | Common Stock | 17,371 | 17,371 | D |
| Stock Options (Right to Buy)F5 | $106.59 | Aug 18, 2016 | A | 13,028 | A | — | Aug 18, 2023 | Common Stock | 13,028 | 13,028 | D |
| Restricted Stock UnitsF6,F5 | — | Aug 18, 2016 | A | 2,111 | A | — | — | Common Stock | 2,111 | 2,111 | D |
| Stock Options (Right to Buy)F1 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to Buy)F2 | $97.23 | holding | — | — | — | — | Jul 9, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Options (Right to Buy)F3 | $88.23 | holding | — | — | — | — | Jan 4, 2023 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- F250,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
- F3Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.
- F4Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- F5Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F6Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.